This daily pill is the most promising preventer of HIV yet
When pre-exposure prophylaxis, or PrEP (Truvada), first hit the market, critics were skeptical of the pill's claims that it could keep clients HIV-free if it at the same time lured people into believing they could have safe sex condom-free. However, 657 clients and more than two years later, it looks like that has, in fact, been the case: Not one person on the pill caught the virus, The New York Times reports.
However, critics who suggested the security provided by PrEP — which is close to 100 percent successful — would lead to a false sense of security about sexually transmitted diseases appear to have been correct. Gay men in the study did use fewer condoms, and about half became infected with syphilis, gonorrhea, or Chlamydia within a year. Forty percent said their condom use decreased, although the vast majority said their number of sexual partners remained the same. At least there's this: While HIV (which can develop into AIDS) is controlled with antiretroviral drugs taken for life, most other STDs are treated with a run of antibiotics.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
'Make legal immigration a more plausible option'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
LA-to-Las Vegas high-speed rail line breaks ground
Speed Read The railway will be ready as soon as 2028
By Peter Weber, The Week US Published
-
Israel's military intelligence chief resigns
Speed Read Maj. Gen. Aharon Haliva is the first leader to quit for failing to prevent the Hamas attack in October
By Justin Klawans, The Week US Published
-
Doctors are taking on dental duties in low-income areas
Under the radar Physicians are biting into the dentistry industry
By Devika Rao, The Week US Published
-
The never-grow-older generations are here
In the spotlight Entering the age of not-aging
By Devika Rao, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
How love impacts your health
The Explainer Turns out you actually can die of a broken heart
By Devika Rao, The Week US Published
-
Addicted to screens? 4 tips for a digital detox that sticks.
the explainer Taking a break from your phone can be good for you
By Theara Coleman, The Week US Published